These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10715561)

  • 1. Effects of metabolic fragments of [Arg(8)]-vasopressin on nerve growth in cultured hippocampal neurons.
    Tarumi T; Sugimoto Y; Chen Z; Zhao Q; Kamei C
    Brain Res Bull; 2000 Mar; 51(5):407-11. PubMed ID: 10715561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arg8]-vasopressin-induced increase in intracellular Ca2+ concentration in cultured rat hippocampal neurons.
    Mihara T; Tarumi T; Sugimoto Y; Chen Z; Kamei C
    Brain Res Bull; 1999 Jul; 49(5):343-7. PubMed ID: 10452354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin-induced calcium signaling in cultured hippocampal neurons.
    Brinton RD; Gonzalez TM; Cheung WS
    Brain Res; 1994 Oct; 661(1-2):274-82. PubMed ID: 7834378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular pathways of V(1) and V(2) receptors activated by arginine vasopressin in rat hippocampal neurons.
    Omura T; Nabekura J; Akaike N
    J Biol Chem; 1999 Nov; 274(46):32762-70. PubMed ID: 10551836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin-induced neurotrophism in cultured hippocampal neurons via V1 receptor activation.
    Brinton RD; Monreal AW; Fernandez JG
    J Neurobiol; 1994 Apr; 25(4):380-94. PubMed ID: 8077964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells.
    Perdonà E; Arban R; Griffante C
    Eur J Pharmacol; 2012 Mar; 679(1-3):16-23. PubMed ID: 22285855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze.
    Mishima K; Tsukikawa H; Inada K; Fujii M; Iwasaki K; Matsumoto Y; Abe K; Egawa T; Fujiwara M
    Eur J Pharmacol; 2001 Sep; 427(1):43-52. PubMed ID: 11553362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.
    Nakamura S; Yamamura Y; Itoh S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Ogawa H; Shinohara T; Kan K; Tanada Y; Teramoto S; Sumida T; Nakayama S; Sekiguchi K; Kambe T; Tsujimoto G; Mori T; Tominaga M
    Br J Pharmacol; 2000 Apr; 129(8):1700-6. PubMed ID: 10780976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
    J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin(4-9) fragment activates V1a-type vasopressin receptor in rat supraoptic neurones.
    Gouzènes L; Dayanithi G; Moos FC
    Neuroreport; 1999 Jun; 10(8):1735-9. PubMed ID: 10501566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of a novel AVP(4-9) binding site in rat hippocampus.
    Nakayama Y; Takano Y; Shimohigashi Y; Tanabe S; Fujita T; Kamiya H; Tsujimoto G
    Brain Res; 2000 Mar; 858(2):416-23. PubMed ID: 10708695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin-induced calcium signaling in cultured hippocampal neurons.
    Brinton RD; Gonzalez TM; Cheung WS
    Brain Res; 1994 Dec; 667(1):151-9. PubMed ID: 7895079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine vasopressin fragment AVP(4-9)facilitates induction of long-term potentiation in the hippocampus.
    Chepkova AN; Kapai NA; Skrebitskii VG
    Bull Exp Biol Med; 2001 Feb; 131(2):136-8. PubMed ID: 11391395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of FE 202158, a novel, potent, selective, and short-acting peptidic vasopressin V1a receptor full agonist for the treatment of vasodilatory hypotension.
    Laporte R; Kohan A; Heitzmann J; Wisniewska H; Toy J; La E; Tariga H; Alagarsamy S; Ly B; Dykert J; Qi S; Wisniewski K; Galyean R; Croston G; Schteingart CD; Rivière PJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):786-96. PubMed ID: 21411496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin.
    Scharschmidt LA; Dunn MJ
    J Clin Invest; 1983 Jun; 71(6):1756-64. PubMed ID: 6408123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of [Arg8]-vasopressin on regional cerebral blood flow in spontaneously hypertensive rats.
    Azuma N; Sugimoto Y; Mio M; Shinomiya K; Kamei C
    Methods Find Exp Clin Pharmacol; 2003 Apr; 25(3):193-7. PubMed ID: 12743623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze.
    Mishima K; Tsukikawa H; Miura I; Inada K; Abe K; Matsumoto Y; Egashira N; Iwasaki K; Fujiwara M
    Neuropharmacology; 2003 Mar; 44(4):541-52. PubMed ID: 12646291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.